Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium
Multi-drug and extensively drug-resistant tuberculosis (MDR/XDR-TB) are considered a serious threat for TB control and elimination. The outcome of these patients is still largely unsatisfactory as of today, with treatment success rates being consistently below 50% at global level. The World Health O...
Main Authors: | Lia D’Ambrosio, Marina Tadolini, Rosella Centis, Raquel Duarte, Giovanni Sotgiu, Stefano Aliberti, Masoud Dara, Giovanni Battista Migliori |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-03-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971214017421 |
Similar Items
-
Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01) -
Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01) -
Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda
by: Joseph Baruch Baluku, et al.
Published: (2021-07-01) -
Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment
by: Giovanni Sotgiu, et al.
Published: (2015-03-01) -
The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB
by: Jeremiah Chakaya, et al.
Published: (2022-11-01)